Projected Growth in Minimal Residual Disease Market: USD 2.55 Billion by 2029 The Minimal Residual Disease market is anticipated to reach USD 2.55 billion by 2029, showing a robust growth rate driven by cancer incidence and technological advancements.

Projected Growth in Minimal Residual Disease Market: USD 2.55 Billion by 2029 #None #Minimal_Residual_Disease #IGRA_Testing #PCR_Technology